Get With The Guidelines® - AFIB Overview
Atrial fibrillation (AFib) affects between 2.7 and 6.1 million Americans, often leading to heart-related complications as well as increasing the risk for stroke fivefold. Get With The Guidelines®- AFIB is the newest addition to the 蜜芽传媒/American Stroke Association's collaborative performance improvement programs. The program is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.
Get With The Guidelines-AFIB supports hospitals in many ways, including:
- access to the most up-to-date research and scientific publications
- a competitive advantage in the healthcare marketplace
- clinical tools and resources
- identification of improvement opportunities
- national and local recognition for hospital team program achievement
- patient education resources
- performance comparison with hospitals
- professional education opportunities, such as workshops and webinars
- Quality & Systems Improvement (QSI) field staff support
- reduction of noncompliance and medical errors through data-driven peer review
Data collection and feedback reporting are performed using the 蜜芽传媒's Patient Management Tool™ (PMT), an online, interactive system provided by IQVIA.
For more information, download Get With The Guidelines-AFIB fact sheets and forms here.
Get With The Guidelines - AFIB is provided by the 蜜芽传媒/American Stroke Association.
Working Together to Advance Cardiovascular Research and Guideline Implementation
Collaborating with the Heart Rhythm Society brings the expertise of the largest U.S. electrophysiology professional organization together with the 蜜芽传媒's leadership in improving healthcare quality.
